Journal of Pharmacogenomics & Pharmacoproteomics

Journal of Pharmacogenomics & Pharmacoproteomics
Open Access

ISSN: 2153-0645

Role of Pharmacogenomics and Pharmacoproteomics in the developement of vaccine for covid 19

Role of Pharmacogenomics and Pharmacoproteomics in the developement ofvaccine for covid 19

Journal of Pharmacogenomics and Pharmacoproteomics is pleased to announce Special issue on "Role of Pharmacogenomics and Pharmacoproteomics in the developement ofvaccine for covid 19".

By controlling devastating and emerging coronavirus disease (COVID)-19, new drug molecules, vaccines, and antibiotics from microbiological to sequence-based approaches have had an enormous impact on world health. Healthcare researchers have always been a leader in innovation. 

The improvements and recent growth that the use of pharmacogenomics and drug designing has seen in the past few years can cover fields that are directly or indirectly, or even be implemented to aid in the development of pharmaceutical products or industrial applications.The fact that a COVID-19 has emerged indicates immune naivety in the infected population, or altered virulence potential or an increase in the pathogen population. The rapid development of vaccines and therapeutics that target these pathogens is therefore essential to limit their spread. 

With the same purpose our Journal “Journal of Pharmacogenomics and Pharmacoproteomics” is announcing Special issue Call for paper on “Role of Pharmacogenomics and Pharmacoproteomics in the developement ofvaccine for covid 19". We welcome both solicited and unsolicited submissions that will contribute to this special issue.

Submission Process 

Special issue articles can include both original unpublished research articles and review articles related to the specific theme

  • Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee.
  • All the articles in special issues should strictly adhere to journal style and formatting.
  • Each special issue can be created with 5-7 articles.
  • All accepted manuscripts can be submitted online via www.longdom.org/submissions/pharmacogenomics-pharmacoproteomics.html or through an email id to [email protected]
  • Submission should be accompanied by a cover letter with reference to the concerned special issue theme.

Please visit Instruction for authors page to know more about article formatting and guidelines: https://www.longdom.org/pharmacogenomicspharmacoproteomics/instructionsforauthors.html

Top